SMARCA4 supports the oncogenic landscape of <i>KRAS</i> -driven lung tumors
Shivani Malik(Salk Institute for Biological Studies), Eric A. Collisson(UCSF Helen Diller Family Comprehensive Cancer Center)
Cited by 4
Related Papers
Tipifarnib potentiates the antitumor effects of PI3Kα inhibition in <i>PIK3CA</i> - and <i>HRAS</i> -dysregulated HNSCC via convergent inhibition of mTOR activity
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0